New cancer clinical trial: Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Published on: May 24, 2018 at 12:00PM
Condition:   Breast Cancer
Intervention:   Drug: apatinib+oral etoposide
Sponsor:   Chinese Academy of Medical Sciences
Recruiting
https://ift.tt/2GRovce